US Patent Issued to Biolinq on April 14 for "Method and system for confirmation of microneedle-based analyte-selective sensor insertion into viable tissue via electrical interrogation" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,337, issued on April 14, was assigned to Biolinq Inc. (San Diego).

"Method and system for confirmation of microneedle-based analyte-selective sensor insertion into viable tissue via electrical interrogation" was invented by Joshua Windmiller (San Diego) and Jared Rylan Tangney (Encinitas, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A system and method to confirm the insertion of an analyte-selective sensor comprising an array of microneedles possessing vertical extent between 200 and 2000 micro metre into viable tissue is disclosed herein. Mechanical insertion of an analyte-selective sensor is firstly attempted by means of an application ...